The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomes.
 
Vishwajith Sridharan
No Relationships to Disclose
 
Mari Mino-Kenudson
Consulting or Advisory Role - AstraZeneca/MedImmune; H3 Biomedicine
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Elsevier
 
James M. Cleary
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Abbvie (Inst); AstraZeneca; BMS (Inst); BMS (Inst); Esperas Pharma; Merck; Merus (Inst); Roche/Genentech (Inst); Tesaro
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Roche
 
Osama E. Rahma
Employment - Outcomes4me
Leadership - Outcomes4me
Honoraria - Alaunus Global; Clinical Care Options; Leerink; Merck; MI Bioresearch; PRMA Consulting
Consulting or Advisory Role - Alcimed; Bayer; Celgene; Defined Health; Five Prime Therapeutics; Genentech; Gfk; GlaxoSmithKline; Imvax; Leerink; Leerink; Maverick Therapeutics; Merck; PureTech; Putnam Associates; Sobi
Research Funding - Amgen (Inst); Merck
Patents, Royalties, Other Intellectual Property - PD-1/PD-L1 (Inst); Pending patent (DFCI 2386.010) (Inst)
Travel, Accommodations, Expenses - Clinical Care Options; Genentech; Merck; PRMA Consulting; PureTech
 
Kimberly Perez
Consulting or Advisory Role - Celgene; Eisai
 
Jeffrey William Clark
Research Funding - Pfizer (Inst)
 
Douglas Adam Rubinson
Consulting or Advisory Role - Augmenix; Boston Scientific
 
Lipika Goyal
Consulting or Advisory Role - Agios; Alentis Therapeutics; AstraZeneca; Debiopharm Group; Exelixis; Genentech; H3 Biomedicine; Incyte; Klus Pharma; QED Therapeutics; Sirtex Medical; Taiho Pharmaceutical
(OPTIONAL) Uncompensated Relationships - Agios; Debiopharm Group; Merck; Taiho Pharmaceutical
 
Fateh Bazerbachi
No Relationships to Disclose
 
Motaz Qadan
Consulting or Advisory Role - Olympus Medical Systems
 
Aparna Raj Parikh
Consulting or Advisory Role - Foundation Medicine; Lilly; Natera; PureTech
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); Tesaro (Inst)
 
Cristina R. Ferrone
No Relationships to Disclose
 
Brenna Casey
No Relationships to Disclose
 
Carlos Fernandez Del-Castillo
No Relationships to Disclose
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; Exact Sciences; MPM Capital; Thrive Earlier Detection Corp
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; Maverick Therapeutics; MPM Capital; Oncorus; TCR2 Therapeutics; Twentyeight-Seven Therapeutics
Research Funding - Stand up to Cancer (Inst)
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Expert Testimony - Boehringer Ingelheim
Other Relationship - TCR2 Therapeutics
 
Keith Lillemoe
No Relationships to Disclose
 
Andrew Louis Warshaw
No Relationships to Disclose
 
Kumar Krishnan
No Relationships to Disclose
 
Yasmin Hernandez-Barco
Consulting or Advisory Role - Nestle Health Science; Takeda